Cronos Group, Inc. (CRON)
3.38
-0.01
(-0.30%)
USD |
NASDAQ |
Aug 28, 16:00
3.375
0.00 (0.00%)
After-Hours: 20:00
Cronos Group EPS Diluted (Quarterly) : 0.0855 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0855 |
| March 31, 2026 | 0.036 |
| December 31, 2025 | -0.0047 |
| September 30, 2025 | 0.0674 |
| June 30, 2025 | -0.1031 |
| March 31, 2025 | 0.016 |
| December 31, 2024 | 0.1131 |
| September 30, 2024 | 0.0216 |
| June 30, 2024 | -0.0229 |
| March 31, 2024 | -0.0059 |
| December 31, 2023 | -0.1178 |
| September 30, 2023 | -0.0044 |
| June 30, 2023 | -0.0215 |
| March 31, 2023 | -0.0504 |
| December 31, 2022 | -0.2083 |
| September 30, 2022 | -0.0975 |
| June 30, 2022 | -0.0538 |
| March 31, 2022 | -0.087 |
| December 31, 2021 | -0.3564 |
| September 30, 2021 | 0.2074 |
| June 30, 2021 | -0.4817 |
| March 31, 2021 | -0.4444 |
| December 31, 2020 | -0.3106 |
| September 30, 2020 | 0.1849 |
| Date | Value |
|---|---|
| June 30, 2020 | -0.3065 |
| March 31, 2020 | 0.2025 |
| December 31, 2019 | 0.1792 |
| September 30, 2019 | 1.618 |
| June 30, 2019 | 0.16 |
| March 31, 2019 | 0.3297 |
| December 31, 2018 | -0.0535 |
| September 30, 2018 | -0.0311 |
| June 30, 2018 | 0.0026 |
| March 31, 2018 | -0.0053 |
| December 31, 2017 | 0.0079 |
| September 30, 2017 | 0.008 |
| June 30, 2017 | 0.0008 |
| March 31, 2017 | -0.0076 |
| December 31, 2016 | 0.0075 |
| September 30, 2016 | -0.0027 |
| June 30, 2016 | -0.031 |
| March 31, 2016 | -0.0073 |
| December 31, 2015 | 0.0374 |
| September 30, 2015 | -0.0076 |
| June 30, 2015 | -0.0162 |
| March 31, 2015 | -0.0792 |
| June 30, 2014 | -0.014 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Lexaria Bioscience Corp. | -1.204 |
| Target Group, Inc. (Canada) | -0.0004 |
| Tilray Brands, Inc. | -0.4291 |
| InMed Pharmaceuticals, Inc. | -0.7327 |
| NervGen Pharma Corp. | -0.2283 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 35.66M |
| Revenue (Quarterly) | 53.01M |
| Total Expenses (Quarterly) | 20.92M |
| Enterprise Value | 506.10M |
| Gross Profit Margin (Quarterly) | 52.96% |
| Profit Margin (Quarterly) | 67.28% |
| Earnings Yield | 5.45% |
| Normalized Earnings Yield | 5.858 |